Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Febrile Encephalopathy (Phase 2/Phase 3)
Autism Spectrum Disorder (Phase 2)
Cerebellar Diseases (Phase 2/Phase 3)
Diffuse Cerebral Sclerosis of Schilder (Phase 2/Phase 3)
Drug Resistant Epilepsy (Phase 2/Phase 3)
Friedreich Ataxia (Phase 3)
Genetic Diseases, Inborn (Phase 2)
Hearing Loss, Noise-Induced (Phase 2)
Hematopoiesis (Phase 2)
Leigh Disease (Phase 2/Phase 3)
Methylmalonic Acid (Phase 2)
Mitochondrial Diseases (Phase 3)
Muscular Diseases (Phase 2)
Neurology (Phase 2)
Parkinson Disease (Phase 2)
Retinal Diseases (Phase 2)
Rett Syndrome (Phase 2)
Tourette Syndrome (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue